Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children
Authors:
- Alessandro PlebaniAPAlessandro Plebani
- Antonella MeiniAMAntonella Meini
- Marco CattaliniMCMarco Cattalini
- Vassilios LougarisVLVassilios Lougaris
- Antonella BugattiABAntonella Bugatti
- Francesca CaccuriFCFrancesca Caccuri
- Arnaldo CarusoACArnaldo Caruso
- 1 December 2020
- journal article
- letter
- Published by Elsevier in Clinical Immunology
- Vol. 221, 108613
Abstract
No abstract availableKeywords
Funding Information
- Seventh Framework Programme (201549, HEALTH-F2-2008-201549)
- Seventh Framework Programme
- Jeffrey Modell Foundation
This publication has 10 references indexed in Scilit:
- SARS-CoV-2 infections in children and young peopleClinical Immunology, 2020
- Development of child immunity in the context of COVID-19 pandemicClinical Immunology, 2020
- Multisystem Inflammatory Syndrome in Children in New York StateNew England Journal of Medicine, 2020
- SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020Eurosurveillance, 2020
- COVID-19 – Considerations for the paediatric rheumatologistClinical Immunology, 2020
- Adult Onset Still’s Disease Associated withMycoplasma pneumoniaeInfection and Hemophagocytic LymphohistiocytosisCase Reports in Medicine, 2016
- Cytokine profiles in Mycoplasma pneumoniae infection-associated hemophagocytic lymphohistiocytosisJournal of Microbiology, Immunology and Infection, 2016
- Evidence of Acute Mycoplasma Infection in a Patient with Incomplete and Atypical Kawasaki Disease: A Case ReportCase Reports in Medicine, 2011
- Mycoplasma pneumoniaeinfection in patients with Kawasaki diseaseKorean Journal of Pediatrics, 2011
- Mycoplasma pneumoniae infection associated with Kawasaki diseaseActa Paediatrica, 2001